ES2119747T3 - Metodo para la preparacion y purificacion de una mezcla de glicosfingolipidos libre de contaminacion por virus no convencionales. - Google Patents

Metodo para la preparacion y purificacion de una mezcla de glicosfingolipidos libre de contaminacion por virus no convencionales.

Info

Publication number
ES2119747T3
ES2119747T3 ES90916737T ES90916737T ES2119747T3 ES 2119747 T3 ES2119747 T3 ES 2119747T3 ES 90916737 T ES90916737 T ES 90916737T ES 90916737 T ES90916737 T ES 90916737T ES 2119747 T3 ES2119747 T3 ES 2119747T3
Authority
ES
Spain
Prior art keywords
preparation
contamination
purification
mixture free
conventional viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90916737T
Other languages
English (en)
Inventor
Valle Francesco Della
Lanfranco Callegaro
Silvana Lorenzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT4174789A external-priority patent/IT1236594B/it
Priority claimed from IT04171690A external-priority patent/IT1243295B/it
Application filed by Fidia SpA filed Critical Fidia SpA
Application granted granted Critical
Publication of ES2119747T3 publication Critical patent/ES2119747T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C07H1/08—Separation; Purification from natural products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL PROCESO DE LA INVENCION SE REFIERE A UN PROCESO PARA LA PREPARACION DE UNA MEZCLA DE GANGLIOSIDOS, LIBRE DE CONTAMINANTES ASOCIADOS CON VIRUS NO CONVENCIONALES QUE AMENAZAN LA VIDA, SIN ALTERAR LAS PROPIEDADES BIOLOGICAS Y FARMACEUTICAS DE LA MEZCLA EN LOS SISTEMAS NERVIOSOS CENTRAL Y PERIFERICO.
ES90916737T 1989-11-17 1990-11-16 Metodo para la preparacion y purificacion de una mezcla de glicosfingolipidos libre de contaminacion por virus no convencionales. Expired - Lifetime ES2119747T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4174789A IT1236594B (it) 1989-11-17 1989-11-17 Metodo per la preparazione e purificazione di una miscela di glicosfingolipidi
IT04171690A IT1243295B (it) 1990-10-18 1990-10-18 Metodo per la preparazione e purificazione di una miscela di glicosfingolipidi priva di contaminanti da virus non convenzionali

Publications (1)

Publication Number Publication Date
ES2119747T3 true ES2119747T3 (es) 1998-10-16

Family

ID=26329145

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90916737T Expired - Lifetime ES2119747T3 (es) 1989-11-17 1990-11-16 Metodo para la preparacion y purificacion de una mezcla de glicosfingolipidos libre de contaminacion por virus no convencionales.

Country Status (22)

Country Link
US (1) US5521164A (es)
EP (1) EP0454818B1 (es)
JP (1) JP3140458B2 (es)
KR (1) KR0177820B1 (es)
CN (1) CN1027895C (es)
AT (1) ATE169926T1 (es)
AU (1) AU649635B2 (es)
CA (1) CA2045142C (es)
DE (1) DE69032578T2 (es)
ES (1) ES2119747T3 (es)
FI (1) FI97138C (es)
HK (1) HK1013294A1 (es)
HU (2) HU210145B (es)
IE (1) IE904135A1 (es)
IL (1) IL96346A (es)
IN (1) IN171530B (es)
NO (1) NO175311C (es)
NZ (1) NZ236059A (es)
PE (1) PE25491A1 (es)
PT (1) PT95917B (es)
WO (1) WO1991007417A1 (es)
YU (1) YU218790A (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1235161B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisogangliosidi
DE69132362T2 (de) * 1991-05-16 2001-04-05 Fidia Spa Verfahren zur herstellung und reinigung von einer glykosphingolipidmischung frei von verunreinigungen durch ungewöhnliche viren
IT1260149B (it) * 1992-04-17 1996-03-28 Fidia Spa Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
US6458761B2 (en) 1999-11-24 2002-10-01 Lore Maria Klett-Loch Synthetic, statistic thymic peptide combination and its use as a preparation with immunological and/or endocrinological effect
JP4444543B2 (ja) * 2000-02-24 2010-03-31 株式会社メニコン プリオンを不活性化する方法およびそれに用いる処理溶液
JP2005527467A (ja) 2001-08-29 2005-09-15 ネオーズ テクノロジーズ， インコーポレイテッド 新規な合成ガングリオシド誘導体およびその組成物
MXPA05009480A (es) 2003-03-06 2006-02-22 Neose Technologies Inc Metodos y composiciones para la sintesis enzimatica de gangliosidos.
US7066261B2 (en) * 2004-01-08 2006-06-27 Halliburton Energy Services, Inc. Perforating system and method
WO2010062197A1 (en) * 2008-11-25 2010-06-03 Eduard Nekrasov Dairy product and process
EP3175857A1 (en) 2009-03-25 2017-06-07 Seneb Biosciences Inc. Glycolipids as treatment for disease
CN101838295B (zh) * 2010-04-14 2015-02-25 李桂凤 一种利用具有特异识别功能色谱介质快速分离纯化神经节苷脂的工业化生产工艺
US8710385B2 (en) 2012-05-07 2014-04-29 Robert Butch Sickels Reliability fire pressure switch
CN105111253B (zh) * 2015-09-18 2018-01-12 重庆寰瑞生物技术有限公司 一种提取分离神经节苷脂的方法
CN109320566B (zh) * 2018-08-14 2022-03-15 四川兴杰象药业有限公司 一种从猪脑髓中提取神经节苷脂的分离纯化制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3346413A (en) * 1964-10-12 1967-10-10 Hooker Chemical Corp Method and apparatus for coating wire and solvent recovery
ES8506323A1 (es) * 1984-01-04 1985-07-01 Bioiberica Procedimiento para la obtencion de un complejo glicoesfingolipidico
JPS60181019A (ja) * 1984-02-28 1985-09-14 Mitsui Toatsu Chem Inc ガングリオシドの抽出方法
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
JPS61180719A (ja) * 1985-02-06 1986-08-13 Mitsui Toatsu Chem Inc ガングリオシドの取得方法
US4710490A (en) * 1985-10-01 1987-12-01 Angio Medical Corporation Compositions containing ganglioside molecules with enhanced angiogenic activity
IT1223408B (it) * 1987-12-09 1990-09-19 Crinos Industria Farmaco Procedimento per la preparazione di monosialoganglioside

Also Published As

Publication number Publication date
JPH04503076A (ja) 1992-06-04
CN1053067A (zh) 1991-07-17
KR0177820B1 (ko) 1999-04-01
DE69032578T2 (de) 1999-04-29
HK1013294A1 (en) 1999-08-20
EP0454818B1 (en) 1998-08-19
WO1991007417A1 (en) 1991-05-30
IE904135A1 (en) 1991-05-22
HU210145B (en) 1995-02-28
PT95917B (pt) 1998-04-30
IL96346A0 (en) 1991-08-16
PT95917A (pt) 1991-09-13
US5521164A (en) 1996-05-28
KR920701225A (ko) 1992-08-11
NO175311C (no) 1994-09-28
CA2045142A1 (en) 1991-05-18
HUT58754A (en) 1992-03-30
NO912780D0 (no) 1991-07-16
CA2045142C (en) 2000-07-18
ATE169926T1 (de) 1998-09-15
YU218790A (sh) 1993-10-20
JP3140458B2 (ja) 2001-03-05
FI97138B (fi) 1996-07-15
IL96346A (en) 1997-06-10
IN171530B (es) 1992-11-07
FI97138C (fi) 1996-10-25
NO912780L (no) 1991-07-16
AU649635B2 (en) 1994-06-02
AU6727590A (en) 1991-06-13
FI913454A0 (fi) 1991-07-17
HU912391D0 (en) 1991-12-30
DE69032578D1 (de) 1998-09-24
NZ236059A (en) 1993-03-26
PE25491A1 (es) 1991-09-12
CN1027895C (zh) 1995-03-15
NO175311B (no) 1994-06-20
EP0454818A1 (en) 1991-11-06

Similar Documents

Publication Publication Date Title
ES2119747T3 (es) Metodo para la preparacion y purificacion de una mezcla de glicosfingolipidos libre de contaminacion por virus no convencionales.
ES2057191T3 (es) Metodo de produccion para una composicion que contiene proteinas.
ES2032802T3 (es) Sucedaneo de la sangre, semisintetico, extrapuro.
AR240990A2 (es) Procedimiento para la separacion de moleculas de intweres biologico,de una mezcla que las contiene."
PT83873B (pt) Processo de preparacao de medicamentos contendo hexadecilfosfocolina
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR9002717A (pt) Composicao,artigo esterilizado por radiacao e processo para esterilizacao de um artigo
PT82580B (pt) Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
PT87880A (pt) Processo para a preparacao de composicoes farmaceuticas anti-virais que contem ciclo-dextrinas
MX9206503A (es) Nuevos derivados de lupano, proceso para su preparacion y composicion farmaceutica que los contiene.
ES2061528T3 (es) Un procedimiento para preparar nuevos derivados de poliamina.
MX9304837A (es) Peptidos capaces de inhibir la actividad de proteasa vih, su preparacion y su uso terapeutico.
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
PT92949A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da cisteina para o tratamento de doencas associadas com infeccoes provocadas por virus da imunodeficiencia humano
ES2134197T3 (es) Vacunas contra el virus del herpes simplex vp16.
BR9204931A (pt) Oligodesoxirribonucleotideos de origem natural,processo para a obtencao dos mesmos,seus usos e composicoes farmaceuticas
ES2078971T3 (es) Produccion de virus y purificacion de proteinas con envoltura virica para uso en vacunas.
DK0426785T3 (da) Præparater og fremgangsmåder til behandling af virale infektioner
ES2192853T3 (es) Compuestos ciclicos utiles en el tratamiento de la dislipidemia, aterosclerosis y diabetes, composiciones farmaceuticas y proceso de preparacion.
ES2072975T3 (es) Mezcla de esterilizante y metodo de esterilizacion.
MX9401172A (es) Derivados fluorados de 4-aminoandrostadienona, procesamiento para su preparacion y composiciones farmaceuticas que los contienen.
BR8803679A (pt) Mistura de substancias,utilizacao e processo para a preparacao de produtos reticulados
PT83253B (pt) Processo para a preparacao de p-acilaminobenzamidas
PT89303A (pt) Processo para a preparacao de tienotriciclos e de composicoes farmaceuticas que os contem
ES2148150T3 (es) Metodo para la preparacion y purificacion de una mezcla de glicoesfingolipidos libre de contaminacion por virus no convencionales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 454818

Country of ref document: ES